- SPACs
- Federal Street Acquisition Corp.
Federal Street Acquisition Corp.
Completed 2019-01-04- CIK 1701821
- FSAC
- IPO 2017-07-19
- $461M trust
- 94 filings
Successfully merged with Agiliti Health, Inc.
- IPO Size
- $460M
- raised at the IPO
- Trust
- $461M
- as of 2017-09-30
- Current Status
- Completed
- from its latest filing
- IPO Year
- 2017
- year it listed
Filings, by quarter
94 filings over 16 quarters; violet bars carry a milestone
- 17 Q2: 6 filings
- 17 Q3: 23 filings
- 17 Q4: 1 filing
- 18 Q1: 6 filings
- 18 Q2: 1 filing
- 18 Q3: 12 filings
- 18 Q4: 18 filings
- 19 Q1: 22 filings
- 19 Q2: 0 filings
- 19 Q3: 0 filings
- 19 Q4: 0 filings
- 20 Q1: 4 filings
- 20 Q2: 0 filings
- 20 Q3: 0 filings
- 20 Q4: 0 filings
- 21 Q1: 1 filing
- S-1 filed 17 Q2
- IPO 17 Q3
- Completed 19 Q1
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
- Registration2017-05-16 Filed S1
- IPO2017-07-19 IPO, search begins
- Definitive AgreementNo merger agreement yet
- Completed2019-01-04 Merger Completed
About
Federal Street Acquisition Corp. is a blank-check company formed to acquire and operate a business, with a primary focus on a healthcare company based in North America. It is affiliated with Thomas H. Lee Partners and intends to apply its management team's operating and value-creation experience to a business combination.
Investment Focus
Healthcare
Geographic Focus
North America
Key Information
As the filings state it
- IPO Date
- 2017-07-19
- Total Redemptions
- $465M
- PIPE
- $750M
- Jurisdiction of Incorporation
- Delaware
- SIC
- 6770
- Completion Date
- 2019-01-04
- Merger Target
- Agiliti Health, Inc.
- SPAC Ticker
- FSAC
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
The team is founded by senior executives of and advisors to Thomas H. Lee Partners. It includes Scott M. Sperling, an experienced private equity investor and THL co-president; Art G. McAleer, with finance and operating experience; Kent R. Weldon, a THL managing director; and Charles P. Holden and Shari H. Wolkon, THL finance and legal executives. The team and board bring experience in healthcare, private equity, business operations and value creation.